199 related articles for article (PubMed ID: 18369363)
1. Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?
Cuspidi C; Esposito A; Negri F; Sala C; Masaidi M; Giudici V; Zanchetti A; Mancia G
Am J Hypertens; 2008 Apr; 21(4):458-63. PubMed ID: 18369363
[TBL] [Abstract][Full Text] [Related]
2. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
Pierdomenico SD; Lapenna D; Cuccurullo F
Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
[TBL] [Abstract][Full Text] [Related]
3. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
[TBL] [Abstract][Full Text] [Related]
4. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
Borzova NV; Gorbachenkov AA
Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
[TBL] [Abstract][Full Text] [Related]
5. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
[TBL] [Abstract][Full Text] [Related]
6. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
7. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
8. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.
Verdecchia P; Angeli F; Gattobigio R; Sardone M; Pede S; Reboldi GP
Am J Hypertens; 2006 May; 19(5):493-9. PubMed ID: 16647622
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
[TBL] [Abstract][Full Text] [Related]
11. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
[TBL] [Abstract][Full Text] [Related]
12. Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.
Schneider MP; Klingbeil AU; Delles C; Ludwig M; Kolloch RE; Krekler M; Stumpe KO; Schmieder RE
Hypertension; 2004 Jul; 44(1):61-6. PubMed ID: 15184349
[TBL] [Abstract][Full Text] [Related]
13. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
[TBL] [Abstract][Full Text] [Related]
15. Arterial hypertension increases left ventricular mass: role of tight blood pressure control.
Ferrara LA; Vaccaro O; Cardoni O; Mancini M; Zanchetti A
J Hum Hypertens; 2004 Sep; 18(9):637-42. PubMed ID: 15014537
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
17. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
18. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
[TBL] [Abstract][Full Text] [Related]
19. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
[TBL] [Abstract][Full Text] [Related]
20. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
